Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2018 1
2020 1
2021 2
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Results by year
Filters applied: . Clear all
Page 1
Pregnancy-Related and Perinatal Outcomes in Women With Multiple Sclerosis: A Nationwide Danish Cross-sectional Study.
Andersen JB, Kopp TI, Sellebjerg F, Magyari M. Andersen JB, et al. Neurol Clin Pract. 2021 Aug;11(4):280-290. doi: 10.1212/CPJ.0000000000001035. Epub 2021 Feb 3. Neurol Clin Pract. 2021. PMID: 34484927 Free PMC article.
OBJECTIVE: To investigate differences in pregnancy-related and perinatal outcomes in women with multiple sclerosis (MS) compared with the general population. METHODS: We conducted a cross-sectional study including pregnancies from January 1, 1997, to D …
OBJECTIVE: To investigate differences in pregnancy-related and perinatal outcomes in women with multiple sclerosis (MS) …
Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis.
Runmarker B, Andersen O. Runmarker B, et al. Brain. 1995 Feb;118 ( Pt 1):253-61. doi: 10.1093/brain/118.1.253. Brain. 1995. PMID: 7895009
The effects of pregnancy were studied in a multiple sclerosis incidence cohort. In order to eliminate interaction bias between the disease and pregnancy, analysis of the risk of relapse during pregnancy and the puerperium was limited to the onse …
The effects of pregnancy were studied in a multiple sclerosis incidence cohort. In order to eliminate interaction bias …
Pharmacotherapeutic considerations in women with multiple sclerosis.
Andersen JB, Magyari M. Andersen JB, et al. Expert Opin Pharmacother. 2020 Sep;21(13):1591-1602. doi: 10.1080/14656566.2020.1774554. Epub 2020 Jun 10. Expert Opin Pharmacother. 2020. PMID: 32521172 Review.
INTRODUCTION: Multiple sclerosis (MS) is a chronically progressive disease of the central nervous system. ...Randomized controlled trials of medication safety - if used during pregnancy, are prohibited for ethical reasons; hence, the evidence is continuously …
INTRODUCTION: Multiple sclerosis (MS) is a chronically progressive disease of the central nervous system. ...Randomized contro …
Pregnancy outcomes after early fetal exposure to injectable first-line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis.
Andersen JB, Sellebjerg F, Magyari M. Andersen JB, et al. Eur J Neurol. 2022 Sep 13. doi: 10.1111/ene.15559. Online ahead of print. Eur J Neurol. 2022. PMID: 36098960
BACKGROUND AND PURPOSE: Data on pregnancy outcomes following fetal exposure to disease-modifying drugs (DMDs) in women with multiple sclerosis (MS) are sparse although growing. METHODS: Data from the Danish Multiple Sclerosis Registry were linke …
BACKGROUND AND PURPOSE: Data on pregnancy outcomes following fetal exposure to disease-modifying drugs (DMDs) in women with multip
Pregnancy Outcomes in Men and Women Treated With Teriflunomide. A Population-Based Nationwide Danish Register Study.
Andersen JB, Moberg JY, Spelman T, Magyari M. Andersen JB, et al. Front Immunol. 2018 Nov 23;9:2706. doi: 10.3389/fimmu.2018.02706. eCollection 2018. Front Immunol. 2018. PMID: 30532753 Free PMC article.
Background: The majority of persons diagnosed with multiple sclerosis (MS) experience their first MS symptoms in the reproductive age. ...Data on TFL-treated patients treated 1st of January 2014-31st of December 2016 for at least 30 consecutive days prior to concept …
Background: The majority of persons diagnosed with multiple sclerosis (MS) experience their first MS symptoms in the reproduct …
Pregnancy in women with MS: Impact on long-term disability accrual in a nationwide Danish Cohort.
Andersen JB, Wandall-Holm MF, Andersen PK, Sellebjerg F, Magyari M. Andersen JB, et al. Mult Scler. 2022 Jul;28(8):1239-1247. doi: 10.1177/13524585211057767. Epub 2021 Nov 18. Mult Scler. 2022. PMID: 34791952
BACKGROUND: Pregnancy is considered to influence the disease course in women with multiple sclerosis (MS). OBJECTIVE: The aim of this study was to investigate the effect of pregnancy on long-term disability accrual in women with MS. METHODS: The Danish …
BACKGROUND: Pregnancy is considered to influence the disease course in women with multiple sclerosis (MS). OBJECTIVE: T …
Pregnancy outcomes following maternal or paternal exposure to teriflunomide in the Danish MS population.
Andersen JB, Wandall-Holm MF, Magyari M. Andersen JB, et al. Mult Scler Relat Disord. 2022 Mar;59:103529. doi: 10.1016/j.msard.2022.103529. Epub 2022 Jan 22. Mult Scler Relat Disord. 2022. PMID: 35091367 Free article.
Background Teriflunomide (TFL) is an oral drug used for treatment of multiple sclerosis (MS). Due to possible teratogenicity it is contraindicated in women of childbearing potential. ...This study investigated the association of adverse perinatal outcomes in newborn …
Background Teriflunomide (TFL) is an oral drug used for treatment of multiple sclerosis (MS). Due to possible teratogenicity i …